Retinoic acid syndrome: a problem of the past?
Tallman
M S
MS
Division of Hematology-Oncology, Northwestern University Medical School, and the Robert H Lurie Comprehensive Cancer Center, Chicago, IL, USA.
D058186:Acute Kidney Injury / Q000139:chemically induced / Q000517:prevention & control; D000970:Antineoplastic Agents / Q000009:adverse effects*; D003907:Dexamethasone / Q000008:administration & dosage / Q000627:therapeutic use; D006801:Humans; D006973:Hypertension / Q000139:chemically induced / Q000517:prevention & control; D015994:Incidence; D015473:Leukemia, Promyelocytic, Acute / Q000097:blood / Q000150:complications / Q000188:drug therapy; D007958:Leukocyte Count; D007964:Leukocytosis / Q000209:etiology; D018921:Leukostasis / Q000209:etiology; D009026:Mortality; D011292:Premedication; D012128:Respiratory Distress Syndrome / Q000139:chemically induced / Q000517:prevention & control; D012307:Risk Factors; D013577:Syndrome; D014212:Tretinoin / Q000009:adverse effects
D000970:Antineoplastic Agents; D014212:Tretinoin; D003907:Dexamethasone